{
  "ticker": "JNJ",
  "target_date": "2025-07-02",
  "actual_date": "2025-07-02",
  "collected_at": "2025-12-08T11:57:51.891694",
  "price": {
    "open": 153.89,
    "high": 154.18,
    "low": 152.97,
    "close": 153.4521942138672,
    "volume": 5544000,
    "change_1d_pct": -0.23,
    "change_7d_pct": 2.8,
    "change_30d_pct": 2.89
  },
  "technicals": {
    "rsi_14": 50.93,
    "sma_20": 151.68,
    "sma_50": 151.13,
    "macd": 0.118,
    "macd_signal": -0.094,
    "macd_histogram": 0.212,
    "bb_upper": 155.89,
    "bb_lower": 147.46,
    "price_vs_sma20_pct": 1.17,
    "price_vs_sma50_pct": 1.54,
    "volume_ratio": 0.69
  },
  "fundamentals": {
    "market_cap": 489227845632,
    "pe_ratio": 19.600243,
    "forward_pe": 19.156462,
    "price_to_book": 6.1631866,
    "price_to_sales": 5.309096,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.29,
    "pct_from_52w_low": 44.34
  },
  "macro": {
    "spy": {
      "price": 618.73,
      "change_1d_pct": 0.45,
      "change_7d_pct": 2.25
    },
    "vix": {
      "level": 16.64,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 96.78
    },
    "gold": {
      "price": 3348.0
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Top Analyst Reports for Johnson & Johnson, Home Depot and Micron",
      "source": "Yahoo",
      "datetime": 1751488200,
      "summary": "MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.",
      "url": "https://finnhub.io/api/news?id=54ec8bb96eae51196085e407fd1131601b698aa79b8d272456d673ee9cd3a2d3"
    },
    {
      "headline": "July Dog Of The Dow's 'Safer' Buy: Verizon",
      "source": "SeekingAlpha",
      "datetime": 1751476862,
      "summary": "Verizon Communications Inc. stands out as the top Dow dividend pick with strong cash flow and value potential. Click for my analysis and why I like VZ.",
      "url": "https://finnhub.io/api/news?id=8925dda184e2b9957f67d5da8f9ed43de30abb890049f9b7f766093e43a0a1fa"
    },
    {
      "headline": "Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?",
      "source": "Yahoo",
      "datetime": 1751461620,
      "summary": "JNJ is banking on Darzalex, Tremfya and new drugs to offset Stelara's LOE and Part D headwinds in Q2 Innovative Medicine sales.",
      "url": "https://finnhub.io/api/news?id=24cb13285fa35443fd672da62e4a29e62c4ac68bae73b5f24b0d49ebc1d4c128"
    },
    {
      "headline": "US FDA approves Regeneron's blood cancer therapy",
      "source": "Finnhub",
      "datetime": 1751455509,
      "summary": "Regeneron Pharmaceuticalssaid on Wednesday the U.S. Food and Drug Administration hasapproved its drug for a type of blood cancer called multiplemyeloma that has recurred in patients who had...",
      "url": "https://finnhub.io/api/news?id=a84d7aa543d4a426e665e20d5c607299ff531d665f7ebac129c314c6c5467db9"
    },
    {
      "headline": "Health Rounds: \u00a03D printed insulin-producing cells show promise for type 1 diabetes in lab tests",
      "source": "Finnhub",
      "datetime": 1751439708,
      "summary": "Insulin-producing human pancreascells can be manufactured with 3D printers, researchers reportedat the International Transplant Congress underway in London. Using a bio-ink made from...",
      "url": "https://finnhub.io/api/news?id=177f995937e63efd34eb99e088a7c6a00e8c2b599532c128268db324dd501c89"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}